Daiken Medical Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	1,508	1,436	1,025	1,151	944
Depreciation & Amortization	232	214	267	314	256
Loss (Gain) From Sale of Assets	2	5	28	1	-
Other Operating Activities	-445	-436	-377	-219	-326
Change in Accounts Receivable	8	50	-99	156	138
Change in Inventory	7	76	29	-122	-248
Change in Accounts Payable	-126	120	113	-71	-266
Change in Other Net Operating Assets	-66	90	3	-77	111
Operating Cash Flow	1,120	1,555	989	1,133	609
Operating Cash Flow Growth	-27.97%	57.23%	-12.71%	86.04%	-57.59%
Capital Expenditures	-166	-162	-198	-202	-309
Sale (Purchase) of Intangibles	-1	-6	-1	-	-3
Other Investing Activities	-1	-	-11	6	1
Investing Cash Flow	-168	-168	-210	-196	-311
Short-Term Debt Issued	-	80	-	-	200
Long-Term Debt Issued	750	-	400	700	800
Total Debt Issued	750	80	400	700	1,000
Short-Term Debt Repaid	-360	-	-	-	-
Long-Term Debt Repaid	-465	-659	-604	-704	-908
Total Debt Repaid	-825	-659	-604	-704	-908
Net Debt Issued (Repaid)	-75	-579	-204	-4	92
Common Dividends Paid	-612	-573	-565	-574	-574
Other Financing Activities	-9	-11	-12	-11	-10
Financing Cash Flow	-696	-1,163	-781	-589	-492
Miscellaneous Cash Flow Adjustments	-	-2	-	-1	-
Net Cash Flow	256	222	-2	347	-194
Free Cash Flow	954	1,393	791	931	300
Free Cash Flow Growth	-31.51%	76.11%	-15.04%	210.33%	-76.43%
Free Cash Flow Margin	9.59%	14.29%	8.66%	10.90%	3.82%
Free Cash Flow Per Share	33.21	48.49	27.53	32.41	10.44
Cash Interest Paid	10	4	3	3	3
Cash Income Tax Paid	443	438	379	218	325
Levered Free Cash Flow	776.38	1,261	776.5	802.5	72.75
Unlevered Free Cash Flow	782	1,264	778.38	804.38	74.63
Change in Working Capital	-177	336	46	-114	-265

Source: S&P Global Market Intelligence. Standard template. Financial Sources.